Clinical Trial Update: Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

View source ↗

Summary

A completed TyTRATE Registry study evaluating dosing and titration of Tyvaso (treprostinil) in patients with pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Tyvaso (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED